Sirolimus Tablet, Sugar Coated
Product Images NDC 59762-1002

7 FDA label images from Mylan Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sirolimus (NDC 59762-1002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sirolimus 01)

Chemical Structure (Sirolimus 01)
Chemical structure of sirolimus, the active ingredient in the drug Sirolimus. The diagram shows the molecular formula with labeled atoms and bonds in a complex ring and chain arrangement.*
FDA Label Image

Figure 1 (Sirolimus 02)

Figure 1 (Sirolimus 02)
A line graph comparing lung function (FEV1 in liters) over 24 months between subjects treated with Sirolimus and a placebo. The x-axis shows time in months, separated into treatment and observation phases, while the y-axis measures FEV1 from 0.0 to 1.6 liters. Data points for Sirolimus and placebo groups include error bars and the number of subjects at various time points is listed below the graph.*
FDA Label Image

Logo (Sirolimus 03)

Logo (Sirolimus 03)
This image shows a label indicating the Greenstone brand for a pharmaceutical product, distributed by Greenstone LLC located in Peapack, New Jersey 07977. It includes the Greenstone logo and distributor information in black text on a white background.*
FDA Label Image

Logo (Sirolimus 04)

FDA Label Image

Principal Display Panel (0.5 mg Tablet Bottle Label)

Principal Display Panel (0.5 mg Tablet Bottle Label)
Sirolimus tablets 0.5 mg sugar-coated oral tablets label. The label includes the Greenstone brand name, NDC 59762-1001-1, a 100-tablet count, storage instructions at 20°C to 25°C, and dispensing information. The product is distributed by Greenstone LLC, Peapack, NJ. The label states 'For oral use only' and 'Rx only.'*
FDA Label Image

Principal Display Panel (1 mg Tablet Bottle Label)

Principal Display Panel (1 mg Tablet Bottle Label)
Label for Greenstone brand sirolimus tablets, 1 mg strength, oral dosage form. The label states it contains 100 tablets and includes storage instructions to keep at 20°C to 25°C (68°F to 77°F). It is distributed by Greenstone LLC in Peapack, NJ, and made in Japan. The label also includes the NDC 59762-1002-1 and directs to dispense with medication guide.*
FDA Label Image

Principal Display Panel (2 mg Tablet Bottle Label)

Principal Display Panel (2 mg Tablet Bottle Label)
The label for Greenstone brand sirolimus tablets shows a 2 mg strength in a sugar-coated tablet form. The package contains 100 tablets and is for oral use only. The label includes storage instructions at room temperature and states it is distributed by Greenstone LLC, Peapack, NJ, and made in Japan. The NDC is 59762-1003-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.